Neil Graham
Director/Board Member presso ASLAN PHARMACEUTICALS LIMITED
Patrimonio netto: - $ in data 31/03/2024
Profilo
Dr. Neil Graham, MD, is an Independent Director at Allakos, Inc., an Independent Non-Executive Director at Zura Bio Ltd., an Independent Non-Executive Director at Aslan Pharmaceuticals Ltd.
and an Independent Director at ASLAN Pharmaceuticals Pte Ltd.
He is on the Board of Directors at Allakos, Inc., Zura Bio Ltd., Aslan Pharmaceuticals Ltd.
and ASLAN Pharmaceuticals Pte Ltd.
Dr. Graham was previously employed as a Chief Medical Officer by Tiziana Life Sciences Ltd.
(United Kingdom), an Independent Non-Executive Director by Pharmaxis Ltd., a Chief Development Officer by Evelo Biosciences, Inc., a VP-Strategic Program Direction & Immunology by Regeneron Pharmaceuticals, Inc., a Senior Vice President-Program & Portfolio by Vertex, Inc., a SVP-Program & Portfolio Management by Trimeris, Inc., a Chief Medical Officer & VP-Clinical Development by XTL Biopharmaceuticals Ltd., an Associate Professor by Johns Hopkins Bloomberg School of Public Health, and a Director-HIV Medical Affairs by Glaxo Wellcome Plc.
He received his doctorate degree from the University of Adelaide.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Neil Graham
| Società | Posizione | Inizio |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Director/Board Member | 18/02/2021 |
| ZURA BIO LIMITED | Director/Board Member | 01/03/2023 |
| ALLAKOS INC. | Director/Board Member | 30/08/2023 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Director/Board Member | - |
Precedenti posizioni note di Neil Graham
| Società | Posizione | Fine |
|---|---|---|
| SYNTARA LIMITED | Director/Board Member | 03/10/2023 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 18/07/2022 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2020 |
| VERTEX, INC. | Corporate Officer/Principal | 01/11/2009 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/02/2007 |
Formazione di Neil Graham
| University of Adelaide | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 8 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| SYNTARA LIMITED | Health Technology |
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| VERTEX, INC. | Technology Services |
| ALLAKOS INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
| Glaxo Wellcome Plc | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Neil Graham
